Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries First Wave BioPharma, Inc. - Common Stock (NQ: FWBI ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, May 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about First Wave BioPharma, Inc. - Common Stock < Previous 1 2 3 4 5 6 7 8 9 Next > 12 Health Care Stocks Moving In Wednesday's Pre-Market Session July 19, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 18, 2023 During Tuesday's trading, 46 companies set new 52-week lows. Via Benzinga Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 18, 2023 Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. Via Benzinga Expert Ratings for First Wave BioPharma June 29, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session July 18, 2023 Via Benzinga Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket July 18, 2023 Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 18, 2023 It's time to start off trading for Tuesday with a breakdown of the biggest pre-market stock movers worth watching this morning. Via InvestorPlace What 4 Analyst Ratings Have To Say About First Wave BioPharma June 13, 2023 Via Benzinga 5 Value Stocks In The Healthcare Sector June 12, 2023 Via Benzinga Expert Ratings for First Wave BioPharma May 15, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session July 17, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023 July 14, 2023 Via Benzinga Crude Oil Rises 1.5%; PepsiCo Earnings Top Views July 13, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 1% on Thursday. The Dow traded up 0.15% to 34,397.80 while the NASDAQ rose 1.40% to 14,114.17. The S&P 500,... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 13, 2023 Via Benzinga Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 13, 2023 Gainers Via Benzinga Nasdaq Rises Over 100 Points; Delta Air Lines Posts Upbeat Results July 13, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday. The Dow traded up 0.13% to 34,392.36 while the NASDAQ rose 0.97% to 14,054.23. The S&P... Via Benzinga Dow Gains Over 100 Points; US Producer Prices Rise 0.1% In June July 13, 2023 U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.31% to 34,454.88 while the NASDAQ rose 0.98%... Via Benzinga Why Are First Wave BioPharma Shares Tanking Today July 13, 2023 First Wave BioPharma Inc (NASDAQ: FWBI) shares are trading lower after the company received topline results from its Phase 2 SPAN trial investigating an enhanced enteric microgranule delivery... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 13, 2023 Via Benzinga Nasdaq Gains Over 50 Points; First Wave BioPharma Shares Spike Higher June 13, 2023 U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.23% to 34,144.24 while the NASDAQ rose 0.42% to 13,518.40. The S&P 500,... Via Benzinga First Wave BioPharma (NASDAQ: FWBI) Makes Significant Progress in Phase 2 SPAN Clinical Trial June 13, 2023 Trial Enrollment Completed for Investigational Therapy of Exocrine Pancreatic Insufficiency First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company Via Spotlight Growth 12 Health Care Stocks Moving In Tuesday's Intraday Session June 13, 2023 Via Benzinga Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 13, 2023 Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 143% to $2.77 after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic... Via Benzinga Crude Oil Rises Sharply; Auddia Shares Plummet June 13, 2023 U.S. stocks traded higher midway through trading, with Dow Jones gaining over 100 points on Tuesday. The Dow traded up 0.42% to 34,210.67 while the NASDAQ rose 0.43% to 13,519.68. The S&P 500, also... Via Benzinga Why First Wave BioPharma Stock Has More Than Doubled Today June 13, 2023 First Wave BioPharma Inc (NASDAQ: FWBI) shares are trading higher after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic insufficiency Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 13, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 08, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday June 07, 2023 On Wednesday, 29 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 29, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Friday May 19, 2023 On Friday, 63 companies hit new 52-week lows. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
